Skip to main content
Clinical Trials/NCT01717261
NCT01717261CompletedPhase 1

Single Pre-Operative Radiation Therapy (SPORT) for Low Risk Breast Cancer

Maisonneuve-Rosemont Hospital1 site in 1 country10 target enrollmentStarted: August 1, 2012Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
10
Locations
1
Primary Endpoint
Acute toxicity

Study Overview

Brief Summary

The purpose of this study is to determine if partial breast irradiation administered in a single preoperative fraction is tolerable.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
60 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Female aged 60 years or older.
  • •Invasive ductal carcinoma.
  • •Unifocal disease.
  • •Tumors less than 2cm.
  • •No clinical evidence of nodal disease.
  • •Estrogen receptor status (ER) positive.
  • •Her2 negative.

Exclusion Criteria

  • •Age less than 60 years.
  • •BRCA 1 and/or BRCA 2 mutation.
  • •Tumour histology limited to lobular carcinoma only.
  • •Neoadjuvant hormonal manipulation or chemotherapy.
  • •More than one primary tumour in different quadrants of the same breast.
  • •Inability to view tumor on imaging.

Arms & Interventions

Single Pre-Operative Radiation Therapy

Experimental

Intervention: Single Pre-Operative Radiation Therapy (Radiation)

Outcomes

Primary Outcomes

Acute toxicity

Time Frame: 6 months

Assess acute toxicity and wound healing complications from the preoperative radiation treatment as per NCI CTCAE Common Toxicity Scale.

Secondary Outcomes

  • Cosmetic outcome(5 years)
  • Chronic toxicity(2 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael Yassa

Radiation Oncologist

Maisonneuve-Rosemont Hospital

Study Sites (1)

Loading locations...

Similar Trials